Heart Failure with Preserved Ejection Fraction and 30-Day Readmission.
30-day readmission
HFpEF
HFrEF
HOSPITAL score
Heart Failure
LACE index
Journal
Clinical medicine & research
ISSN: 1554-6179
Titre abrégé: Clin Med Res
Pays: United States
ID NLM: 101175887
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
05
08
2019
revised:
19
02
2020
accepted:
13
03
2020
pubmed:
29
4
2020
medline:
26
10
2021
entrez:
29
4
2020
Statut:
ppublish
Résumé
Several studies identify heart failure (HF) as a potential risk for hospital readmission; however, studies on predictability of heart failure readmission is limited. The objective of this work was to investigate whether a specific type of heart failure (HFpEF or HFrEF) has a higher association to the rate of 30-day hospital readmission and compare their predictability with the two risk scores: HOSPITAL score and LACE index. Retrospective study from single academic center. Sample size included adult patients from an academic hospital in a two-year period (2015 - 2017). Exclusion criteria included death, transfer to another hospital, and unadvised leave from hospital. Baseline characteristics, diagnosis-related group, and ICD diagnosis codes were obtained. Variables affecting HOSPITAL score and LACE index and types of heart failure present were also extracted. Qualitative variables were compared using Pearson chi The sample size of adult patients in the study period was 1,916. All eligible cohort of patients who were readmitted were analyzed. Cumulative score indicators of HOSPITAL Score, LACE index (including the Charlson Comorbidity Index) predicted 30-day readmissions with Our data from an academic tertiary care center supports HFpEF as an independent risk factor for readmission. Multidisciplinary management of HFpEF may be an important target for interventions to reduce hospital readmissions.
Identifiants
pubmed: 32340982
pii: cmr.2020.1521
doi: 10.3121/cmr.2020.1521
pmc: PMC7735447
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
126-132Informations de copyright
Copyright © 2020 Marshfield Clinic Health System.
Références
Clin Med Insights Cardiol. 2018 Jan 08;12:1179546817751609
pubmed: 29343997
JAMA Intern Med. 2016 Apr;176(4):496-502
pubmed: 26954698
CMAJ. 2010 Apr 6;182(6):551-7
pubmed: 20194559
BMJ Open. 2017 Jul 13;7(7):e016921
pubmed: 28710226
JAMA. 2003 Jan 8;289(2):194-202
pubmed: 12517230
Prog Cardiovasc Dis. 2016 Jan-Feb;58(4):379-85
pubmed: 26432556
Int J Cardiol. 2017 Dec 1;248:246-251
pubmed: 28801153
Circ Heart Fail. 2010 Jan;3(1):97-103
pubmed: 19903931
J Am Coll Cardiol. 2005 Sep 20;46(6):e1-82
pubmed: 16168273
Med Care. 2017 Mar;55(3):285-290
pubmed: 27755392
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721
BMC Cardiovasc Disord. 2014 Aug 07;14:97
pubmed: 25099997
BMJ Evid Based Med. 2020 Oct;25(5):166-167
pubmed: 31771947
Risk Manag Healthc Policy. 2017 May 10;10:63-70
pubmed: 28546776
Am J Cardiol. 2014 Feb 15;113(4):691-6
pubmed: 24484862
Circulation. 1990 Feb;81(2 Suppl):III48-53
pubmed: 2404638
JMIR Med Inform. 2019 Nov 15;7(4):e13353
pubmed: 31730039
J Hosp Med. 2018 Apr 25;:
pubmed: 29694458
PeerJ. 2017 Mar 29;5:e3137
pubmed: 28367375
Cureus. 2018 Aug 9;10(8):e3122
pubmed: 30338197
Am Heart J. 2016 Sep;179:51-8
pubmed: 27595679
BMJ. 2013 Dec 16;347:f7171
pubmed: 24342737
J Am Heart Assoc. 2018 Apr 23;7(9):
pubmed: 29686028
Pharmacotherapy. 2018 Apr;38(4):406-416
pubmed: 29423950
Circulation. 2019 Apr 16;139(16):e840-e878
pubmed: 30852913